M.D., Founder and CEO, Nabsys
Barrett Bready, was founder of Nabsys and CEO from 2005 until 2014 and then again starting in October, 2015. He grew Nabsys from a single employee to 50 and raised $50 million in venture financing to support the company’s growth. Dr. Bready is an adjunct professor at Brown University where he teaches Biotechnology Management, a course on the business of biotechnology. He serves as a commissioner of the I-195 Redevelopment District Commission, a large land redevelopment project in downtown Providence with a focus on life sciences and other high technology sectors. He has received numerous awards including, in 2011, Rhode Island Innovator of the Year from Providence Business News. Dr. Bready received an M.D. and an Sc.B. in physics from Brown University, both as part of Brown’s Program in Liberal Medical Education (PLME).
Whole Genome Mapping… Now in HD
Most nucleotides involved in human genomic variation are part of structural variants. SVs are not called reliably by NGS. High definition whole genome mapping uses electronic detection to generate high-density maps with sub-diffraction- limit resolution. This information can be used to call SVs with high sensitivity and specificity in a pipelined way.